171 related articles for article (PubMed ID: 566232)
1. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
Bruni B; Gamba S; Regis G; Turco GL
Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
[TBL] [Abstract][Full Text] [Related]
2. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
[No Abstract] [Full Text] [Related]
3. [The antigenicity of various new chromatographically purified depot insulin preparations].
Graber D; Fankhauser S
Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
[No Abstract] [Full Text] [Related]
5. The production and characteristics of anti-insulin, anti-A-component and anti-proinsulin antibodies in patients treated with monocomponent or conventional insulin.
Kawazu S; Kanazawa Y; Miki E; Hayashi M; Sando H; Kajinuma H; Iwamoto Y; Akanuma Y; Kosaka K
Acta Diabetol Lat; 1979; 16(4):339-51. PubMed ID: 399151
[TBL] [Abstract][Full Text] [Related]
6. Controlled study comparing treatment with monocomponent insulin and conventional insulin in patients with lipoatrophy.
Czyzyk A; Rogala H; Lawecki J
Acta Diabetol Lat; 1989; 26(1):17-26. PubMed ID: 2665407
[TBL] [Abstract][Full Text] [Related]
7. Treatment of insulin lipoatrophy with monocomponent insulin.
Teuscher A
Diabetologia; 1974 Jun; 10(3):211-4. PubMed ID: 4845721
[No Abstract] [Full Text] [Related]
8. Comparison of insulin antibody levels during the first 3 years of treatment of adult diabetics with monocomponent porcine lente-insulin and single peak beef NPH insulin.
Wajchenberg BL; Thomsen YG; Toledo e Souza IT; Germek OA
Horm Metab Res; 1986 Aug; 18(8):535-9. PubMed ID: 3758926
[TBL] [Abstract][Full Text] [Related]
9. Antigenicity of "monocomponent" pork insulin in diabetic subjects.
Yue DK; Turtle JR
Diabetes; 1975 Jul; 24(7):625-32. PubMed ID: 1171804
[TBL] [Abstract][Full Text] [Related]
10. Insulin antibodies and clinical complications in diabetics treated for five years with lente or sulfated insulin.
Little JA; Lee R; Sebriakova M; Csima A
Diabetes; 1977 Oct; 26(10):980-8. PubMed ID: 561729
[No Abstract] [Full Text] [Related]
11. [Clinical experiences with monocomponent insulins].
Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
[TBL] [Abstract][Full Text] [Related]
12. Insulin antibodies in diabetics receiving a single type of insulin.
Mincu I; Cheţa D
Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
[TBL] [Abstract][Full Text] [Related]
13. [Immunogenicity of MC Lente Novo insulin].
Rogala H; Lawecki J; Czyzyk A
Pol Arch Med Wewn; 1986 Sep; 76(3):172-6. PubMed ID: 3554163
[No Abstract] [Full Text] [Related]
14. Clinical trial with monocomponent lente insulins. Preliminary report.
Bruni B; D'Alberto M; Osenda M; Ricci C; Turco GL
Diabetologia; 1973 Dec; 9(6):492-8. PubMed ID: 4589824
[No Abstract] [Full Text] [Related]
15. Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.
Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
Diabetologia; 1974 Jun; 10(3):233-6. PubMed ID: 4845724
[No Abstract] [Full Text] [Related]
16. Behaviour of insulin antibodies in diabetics treated with different insulins.
Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
[TBL] [Abstract][Full Text] [Related]
17. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
[TBL] [Abstract][Full Text] [Related]
18. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].
Bruni KB; Neirotti R; Albonico G; Gamba S; Regis G; D'Adda A; Soldano E; Bruni B
Ann Osp Maria Vittoria Torino; 1976; 19(16):7-26. PubMed ID: 1027349
[TBL] [Abstract][Full Text] [Related]
19. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
Anderson OO
Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
[TBL] [Abstract][Full Text] [Related]
20. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin.
Kurtz AB; Matthews JA; Mustaffa BE; Daggett PR; Nabarro JD
Diabetologia; 1980; 18(2):147-50. PubMed ID: 6988274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]